+499.5%
MRNA vs QS
-28.5%
+527.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | QS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.6% | -2.8% | -2.4% |
| 7D | +5.5% | -2.3% | +7.8% | +6.2% |
| 30D | +158.7% | -0.7% | +159.5% | +162.1% |
| 3M | +182.1% | -39.6% | +221.8% | +215.5% |
| 6M | +151.8% | -21.7% | +173.5% | +165.8% |
| YTD | +393.6% | -47.4% | +441.0% | +449.3% |
| 1Y | +499.5% | -28.4% | +527.8% | +590.9% |
| All | +499.5% | -28.5% | +527.9% | +590.9% |
Cumulative growth
Daily Returns
Daily percentage return beside QS.
Daily Out/Under-Performance
Portfolio return minus QS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × QS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded QS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling